Clinical Trial Update: A Trial of Selinexor, Ruxolitinib and Methylprednisolone [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigates a combination of selinexor, ruxolitinib, and methylprednisolone in adults with relapsed or refractory multiple myeloma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• Ruxolitinib (ruxolitinib)
• Selinexor (selinexor)

Snippet

Sponsor: Oncotherapeutics | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 1 | Status: RECRUITING